Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Tumor necrosis factor receptor superfamily member 11b (TNFRSF11B), also known as osteoprotegerin (OPG), is a secreted soluble decoy receptor encoded by the TNFRSF11B gene. It contains extracellular cysteine-rich ligand-binding domains but lacks transmembrane and intracellular signaling regions. Under physiological conditions, soluble TNFRSF11B binds RANKL and can also interact with TRAIL, thereby limiting ligand access to signaling receptors. Insufficient TNFRSF11B-mediated ligand sequestration can increase free RANKL availability and enhance RANK-dependent responses in bone microenvironments. Different bone compartments generate distinct ligand levels, requiring soluble decoy-receptor pools to help maintain balanced skeletal signaling.
Variants within the TNFRSF11B coding region may alter ligand-binding affinity and thereby modify decoy-receptor activity. TNFRSF11B is released into extracellular fluids rather than stably embedded in the plasma membrane, distinguishing it from signaling TNF-receptor-family proteins. Its soluble localization enables it to regulate ligand bioavailability without directly initiating intracellular signaling. Reduced TNFRSF11B activity can increase free RANKL and weaken antagonism of RANK-mediated signaling, supporting its value as a research target in bone-remodeling and TNF-superfamily decoy-receptor studies.
Fig. 1 Working model of RANKL‑RANK‑TNFRSF11B (OPG) bone‑remodeling signalling axis. Secreted TNFRSF11B (OPG) may function as a decoy receptor to sequester RANKL and restrain RANK‑mediated osteoclast differentiation.1
The biological functions of soluble TNFRSF11B decoy receptor protein are focused on sustained RANKL sequestration and skeletal cell-signal coordination:
Creative Biolabs offers purified TNFRSF11B soluble protein samples produced under unified preparation workflows, including full-length TNFRSF11B constructs and isolated ligand-binding domain variants. Truncated fragments may not fully reproduce ligand-sequestration behavior, while full-length forms suit research focused on RANKL capture and decoy-receptor interactions. All batches receive uniform quality screening. Functional observations may be carried out under simulated extracellular aqueous conditions. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length TNFRSF11B samples retain intact ligand-binding surfaces after standardized purification, supporting reliable detection of transient receptor-ligand contacts for comparative functional analysis.
Not finding the protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable TNFRSF11B expression cell research models with varied expression levels, applicable to studies of TNFRSF11B secretion and extracellular ligand-receptor interactions. Sample evaluation includes sustained target expression detection and preliminary ligand-interaction observation, enabling side-by-side comparison of ligand-sequestration behaviors under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in ligand-sequestration efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-TNFRSF11B recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for secreted protein detection and identification of receptor-ligand molecular complexes. The antibody series can work alongside common laboratory detection reagents to support multi-dimensional observation of target distribution within skeletal tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for TNFRSF11B research:
TNFRSF11B might act as a TNF-superfamily decoy receptor and participate in extracellular ligand sequestration to moderate ligand-driven cellular responses.
TNFRSF11B expression status could alter local TNF-ligand sequestration efficiency and bone-cell signal output, serving as a major regulatory mediator of skeletal tissue biological processes.
No, all TNFRSF11B related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material designs and functional tests are optimized exclusively for basic laboratory research scenarios, without matching clinical application standards.
Offerings include full-length TNFRSF11B protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on skeletal signal homeostasis and TNF-ligand decoy-mediated modulation.
Laboratory observation schemes may include receptor-ligand interaction tests to analyze molecular-binding behaviors under simulated extracellular environments.
